Investor Conference Call and KOL Forum From TCT 2022 Discussing DurAVR™ Clinical Data to be Hosted on Sept 19, 2022 at 8AM ET BRISBANE, Australia & EGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece native shaped aortic valve, announced today … [Read more…]

In less than two years, Gilead has more than doubled the cost of its HIV medication, Descovy, for the lifesaving 340B program from $445.11 in Q3, 2020 to $987.55 in Q2, 2022 AHF will host a protest Wednesday, Sept. 14th targeting Gilead Sciences—”Greediad”—and its investors over its AIDS drug pricing during the Baird Global Healthcare … [Read more…]

MILWAUKEE–(BUSINESS WIRE)–Physicians Realty Trust (NYSE:DOC) (the “Company”), through a joint venture with Dallas, Texas based MedProperties Realty Advisors, LLC (“MedProperties”) is proud to announce the closing of the acquisition of Calko Medical Center. This Class-A, free-standing facility, built in 2013, contains 85,567 rentable square feet, anchored by Maimonides Medical Center and physicians associated with Maimonides, … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–#GeneCentric—GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the poster presentation of further clinical validation data for PurIST℠, a novel RNA-expression test, in collaboration with Tempus. PurIST identifies patients with the classical subtype of pancreatic ductal adenocarcinoma (PDAC) that are likely to experience longer overall survival (OS) … [Read more…]

TUCSON, Ariz.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners, LLC dba P3 Health Partners-Arizona (“P3 Arizona”) has acquired the practice of Dr. Leonardo Serfino, M.D., in Sierra Vista, Ariz. Dr. Serfino, who specializes in internal medicine, will continue to support his … [Read more…]

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) today announced that longtime executive Bruce Moore, president – service line and operations integration, will retire at the end of the year after a 40-year career with the company. Under Moore’s leadership HCA Healthcare’s network of care capabilities have grown considerably. This includes a behavioral health services platform … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, announced today that it will effect a 1-for-50 reverse split of its common stock effective as of 4:01 p.m. Eastern Time on September 13, 2022. Commencing with the opening of trading on The … [Read more…]

Tracy L. Faber to Retire After More Than a Decade at the Company IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) today announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer (CHRO). Ms. Smith will succeed Tracy L. Faber, McKesson’s current CHRO, who will be retiring after an accomplished … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to SY-5609 for the treatment of pancreatic cancer. SY-5609, a highly selective and potent oral cyclin-dependent kinase 7 (CDK7) inhibitor, … [Read more…]